Lung cancer seems to have different epidemiological, biomolecular and clinical characteristics in females than in males, with a better prognosis for women. The aim of the study is to determine gender differences in lung adenocarcinoma in terms of androgen (AR), estrogen (ER)α and progesterone (PgR) receptors expression and their impact on outcome.
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex / Berardi, Rossana; Morgese, Francesca; Santinelli, Alfredo; Onofri, Azzurra; Biscotti, Tommasina; Brunelli, Alessandro; Caramanti, Miriam; Savini, Agnese; De Lisa, Mariagrazia; Ballatore, Zelmira; Pompili, Cecilia; Salati, Michele; Mazzanti, Paola; Torniai, Mariangela; Cascinu, Stefano. - In: ONCOTARGET. - ISSN 1949-2553. - ELETTRONICO. - (2016). [10.18632/oncotarget.12244]
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex
BERARDI, ROSSANA;MORGESE, FRANCESCA;SANTINELLI, ALFREDO;BALLATORE, ZELMIRA;TORNIAI, MARIANGELA;
2016-01-01
Abstract
Lung cancer seems to have different epidemiological, biomolecular and clinical characteristics in females than in males, with a better prognosis for women. The aim of the study is to determine gender differences in lung adenocarcinoma in terms of androgen (AR), estrogen (ER)α and progesterone (PgR) receptors expression and their impact on outcome.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
